Internal Medicine Department
Hematology Division

Wayne F. Green, PhD

Email:  wayne.green@cores.utah.edu

Web:  University of Utah Flow Cytometry Core Facility

Education:

1973 – 1978   Ph.D. in Microbiology/Immunology, Wake Forest University, Winston-Salem, North Carolina

1967 – 1970    M.S. in Microbiology/Immunology, Wake Forest University, Winston-Salem, North Carolina

1963 – 1967    B.S. in Biology, Bucknell University, Lewisburg, Pennsylvania
 

Other:

1994 – today    Director of the University of Utah Flow Cytometry Core Facility

Bibliography

  1. Ford C, Green W, Warenski S, Petersen F. (2004). The effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant, 33, 901.
  2. Slayton W, Spangrude G, Chen Z, Green W, Virshup D. (2002). Clonal trisomy 21 arising in a hematopoietic progenitor in a patient with transient myeloproliferative disorder. J Pediatr Hematol Oncol, 24, 224.
  3. Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL. (2000). Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Blood, 96(8), 2746-54.
  4. Wiesmann A, Kim M, Georgelas A, Searles AE, Cooper DD, Green WF, Spangrude GJ. (2000). Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta. Exp Hematol, 28(2), 128-39.
  5. Kwak DJ, Augustine NH, Borges WG, Joyner JL, Green WF, Hill HR. (2000). Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci. Infect Immun, 68(1), 320-7.
  6. Bills AC, Green WF, Perkins S, Tsodikov A, Carey M, Petersen FB, Kelley LK. (1999). Cytokeratin positive cells in peripheral blood stem cell collections from normal donors and patients with non-epithelial cell derived tumors. Cytotherapy, 1, 389.
  7. Kozek-Langenecker SA, Mohammad SF, Masaki T, Green WF, Kamerath C, Cheung AF. (1999). Evaluation of the effects of aprotinin on platelets in vitro using whole blood flow cytometry. Kidney Int, 56, 299.
  8. Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE. (1998). Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Oncogene, 17(9), 1119-30.
  9. Perou CM, Leslie JD, Green W, Li L, Ward DM, Kaplan J. (1997). The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem, 272(47), 29790-4.
  10. Rollins-Smith LA, Flajnik MF, Blair PJ, Davis AT, Green WF. (1997). Involvement of thyroid hormones in the expression of MHC class I antigens during ontogeny in Xenopus. Dev Immunol, 5(2), 133-44.
  11. Chapman A, Stewart SJ, Nepom GT, Green WF, Crowe D, Thomas JW, Miller GG. (1996). CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles. J Immunol, 157(11), 4771-80.
  12. Kelley LL, Green WF, Hicks GG, Bondurant MC, Koury MJ, Ruley HE. (1994). Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol Cell Biol, 14(6), 4183-92.
  13. Dai CH, Krantz SB, Green WF, Gilbert HS. (1994). Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br J Haematol, 86(1), 12-21.
  14. Thompson JS, Bryne JE, Hempel HO, Oldfather JW, Green WF, Crowe DO, Sanfilippo F, MacQueen JM, McCalmon RN, Tardiff GN, et al. (1993). Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients. Transplant Proc, 25(1 Pt 1), 251-4.
  15. Zaoui P, Green W, Hakim RM. (1991). Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Kidney Int, 39(5), 1020-6.
  16. Green WF, Stelzer GT. (1988). Interlaboratory comparison of flow cytometric lymphocyte phenotyping analyses: implications for standardization and quality control. Cytometry Suppl, 3, 23-8.
  17. Niblack G, Johnson K, Williams T, Green W, Richie R, MacDonell R. (1987). Antibody formation following administration of antilymphocyte serum. Transplant Proc, 19(1 Pt 3), 1896-7.
  18. Ivey GL 3rd, Richie RE, Niblack GD, Johnson HK, MacDonell RC Jr, Green WF. (1985). Renal transplantation. A 20-year experience in a Veterans Administration Medical Center. Arch Surg, 120(9), 1021-5.
  19. Green WF, Niblack GD, MacDonell RC, Johnson HK, Richie RE. (1985). Altered B lymphocyte levels in the peripheral blood of renal allograft recipients undergoing rejection. Transplant Proc, 17, 635.
  20. Green WF, Niblack GD, Richie RE, Johnson HK, MacDonell RC, Tallent MB. (1984). High-dose versus low-dose steroid therapy in conjunction with rabbit anti-human lymphocyte serum: flow cytometric monitoring of lymphocyte parameters. Transplant Proc, 16(6), 1517-9.
  21. Niblack GD, Johnson HK, Richie RE, Green WF, MacDonell RC, Ynares C, Tallent MB. (1984). Immunologic monitoring of patients awaiting transplantation and subjected to lymphocyte removal. Transplant Proc, 16(6), 1443-5.
  22. Chang LY, Shults KE, McCurley TL, Green WF, Niblack GD, Colley DG. (1984). Analysis of murine lymphocytes in draining lymph nodes after vaccination by irradiated Schistosoma mansoni cercariae. Fed Proc, 43, 1515.
  23. Richie RE, Niblack GD, Johnson HD, Green WF, MacDonell RC, Turner BI, Tallent MB. (1983). Factors influencing outcome of kidney transplant. Ann Surg, 197, 655.
  24. Green WF, Niblack GD, Johnson HK, Richie RE, Tallent MB, MacDonnell R, Turner B, Harbison P, Ganaway S. (1982). Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts. Transplant Proc, 14(2), 282-6.
  25. Green WF, Colley DG. (1981). Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection. Proc Natl Acad Sci U S A, 78(2), 1152-6.
  26. Colley DG, Green WF. (1980). Immunoregulation during murine Schistosoma mansoni infection. Fed Proc, 39, 1054.